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The concurrent occurrence of thymoma and diffuse large B-cell lymphoma in the thymus has not been
previously reported. We describe a 74-year-old man who presented with general weakness, neck
lymphadenopathy, night sweats, and body weight loss. A right anterior mediastinal mass was found on
computed tomography of the chest. The immunohistochemical stains AE1/AE3, CD20, CD3, and MUM-1
conﬁrmed the different components of the mediastinal tumor. A heavy-chain gene clonality assay and
light-chain gene clonality assay conﬁrmed the B-cell clonality of the mediastinal tumor and neck lymph
node. The patient had received a complete course of chemotherapy, and the result of positron emission
tomographyecomputed tomography showed complete remission. The pathologic report of this mass
revealed composite type A thymoma and diffuse large B-cell lymphoma. If concurrent or composite
thymoma and lymphoma are suspected, a thorough examination of the thymoma with a combination of
ancillary studies is recommended to rule out the possibility of concurrent lymphoma.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
The most common thymic tumors in adults are thymomas, fol-
lowed by mediastinal lymphomas, some of which arise from the
mediastinal lymph nodes [1]. Patients with thymomas have been
reported to have an increased incidence of subsequent malignancy,
or concurrent malignant neoplasms. Engels et al [2] published a
large population-based study that reported that 9% of patients with
invasive thymoma had subsequent malignancies, a risk that
signiﬁcantly increased in digestive site cancers (2.5%), non-Hodg-
kin's lymphoma (1%), and soft tissue sarcoma (0.3%). Four of seven
patients with non-Hodgkin's lymphoma in the above study had B-
cell tumors diagnosed by immunophenotyping [2]. Khoury et al
also described secondary malignant neoplasms in 8e31% of pa-
tients with thymoma [3]. The most common concurrent or com-
posite lymphoma in the thymus associated with a thymoma is T-aohsiung Medical University
: þ886 7 3208233; fax: þ886
elief Tzu Chi Foundation. Publishecell lymphoma/leukemia. To the best of our knowledge, there are
only two case reports of composite B-cell lymphomas and thymo-
mas. We describe a case of a thymic tumor composed of a type A
thymoma and a diffuse large B-cell lymphoma (DLBCL).
2. Case Report
A 74-year-old man with a history of hypertension, benign
prostate hyperplasia and gouty arthritis came to the outpatient
clinic of Kaohsiung Municipal Ta-Tung Hospital for a persistent
productive cough with whitish sputum for 1 month. Other associ-
ated symptoms and signs included dizziness, general weakness,
night sweats, poor appetite, and body weight loss of about 3 kg in
1 month (60e57 kg). His physical examination revealed right
posterior supraclavicular lymphadenopathy. Both chest radiog-
raphy and chest computed tomography showed a right side ante-
riormediastinal mass. Hewas transferred to our hospital for further
evaluation. Routine preoperative laboratory test results revealed
normocytic anemia with a red blood cell count of 2.18  1012/L
(male reference range, 4.5e5.9  1012/L), hemoglobin of 6.5 g/L
(male reference range, 14e17.5 g/L), hematocrit of 18.9% (male
reference range, 41.5e50.4 %), and mean corpuscular volume ofd by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. The mediastinal tumor is composed of two distinct cell populations, spindle
cells (right lower) and lymphocytic cells (left upper). The spindle cells have pale
eosinophilic cytoplasm and spindle nuclei. The lymphocytes are large, with angulated
and vesicular nuclei, occasionally prominent nucleoli, and scant cytoplasm. Hema-
toxylineeosin stain, original magniﬁcation 100 and 400 (inset).
Fig. 3. The supraclavicular lymph node has an effaced nodal architecture and is
inﬁltrated by large lymphoid cells. Hematoxylineeosin stain, original magniﬁcation
100 and 400 (inset).
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count was 5.9  109/L (reference range, 4.4e11.3  109/L) with
22.0% lymphocytes (reference range, 20e50%), which were within
normal limits. Under the impression of a thymoma or thymic car-
cinoma with supraclavicular lymph node metastasis, the patient
underwent surgical excision of the anterior mediastinal mass and
excisional biopsy of the right supraclavicular lymph nodes.
Surgical ﬁndings included a 6.7 cm  4.7 cm  3.0 cm, 45.0 g
anterior mediastinal tumor, and right supraclavicular lymph nodes
consisting of four tissue fragments, up to 1.5 cm  1.3 cm  0.8 cm.
Grossly, the anterior mediastinal tumor was grayish and
elastic with a ruptured capsule. On microscopic examination,
sections of the thymus showed a spindle cell tumor with
hemangiopericytoma-like vascular hyperplasia. These spindle tu-
mor cells contained bland nuclei, dispersed chromatin and
inconspicuous nucleoli arranged in solid sheets or in a storiform
pattern. The spindle tumor cells were positive for AE1/AE3, butFig. 2. CD20 is positive in the lymphoid inﬁltrate and negative in the spindle
component. Immunoperoxidase with hematoxylin counterstain, original magniﬁcation
200.negative for CD34, smooth muscle actin, S-100 protein and CD117.
These ﬁndings supported a diagnosis of type A thymoma.
In addition, dense lymphoid inﬁltrates composed of mixed small
and large lymphoid cells were seen at the peripheral soft tissue
surrounding the thymic tumor or intrathymic tumor inﬁltrate
(Fig. 1). The larger lymphoid cells showed centroblastic or immu-
noblastic morphology with some Hodgkin-like cells. Increased
mitotic ﬁgures were also noted. The large lymphoid cells were
positive for CD20 (Fig. 2), MUM-1, bcl-2 and bcl-6 (focal), but
negative for AE1/AE3, CD3, CD5, CD10, CD30 and CD15. The Ki-67
index was about 70%. EpsteineBarr encoding region in situ hy-
bridization was negative. A section of the right supraclavicular
lymph nodes also showed inﬁltration of atypical large lymphoid
cells with focal preserved nodal architecture (Fig. 3). These large
lymphoid cells revealed the same results as the immunohisto-
chemical study of the thymus.Fig. 4. Immunoglobulin k light chain gene clonality assay of the anterior mediastinal
tumor and right supraclavicular lymph node. þ ¼ positive control;  ¼ negative
control; T ¼ anterior mediastinal tumor; LN ¼ supraclavicular lymph node.
Table 1
Literature reports in English of concurrent thymoma and lymphoma.
Authors Age/Sex Thymoma type Lymphoma type
Cory et al (2012) [5] 59/F Invasive lymphocyte-rich thymoma (WHO type B1) Peripheral T-cell lymphoma NOS
Francesca et al (2003) [7] 65/M Epithelial thymoma (WHO type AB) T-cell lymphoblastic lymphoma
Joseph et al (2003) [3] 62/M NS CLL/SLL
Barton (1997) [8] NR＊ Invasive lymphocyte-rich thymoma (WHO type B1) Peripheral T-cell lymphocytosis
Nishioka (1995) [9] 43/M Type 1 thymoma T-lymphoblastic leukemia/lymphoma after
resection of thymoma
Friedman et al (1994) [6] 95/M Invasive thymoma, predominantly spindle cell type T-lymphoblastic leukemia/lymphoma
Lishner et al (1994) [10] 42/M Lymphocytic-type thymoma (WHO type B1) T-g/d leukemia/lymphoma
Smith et al (1994) [11] (I) 30/F
(II) 55/F
Invasive thymoma, predominantly lymphocytic-rich
cortical type (WHO type B1)
Peripheral T-cell lymphocytosis
Macon et al (1991) [12] 64/F Lymphocyte-rich thymoma T-lymphoblastic leukemia/lymphoma at
time of recurrent thymoma
Doll et al (1991) [13] (I) 77/M
(II) 43/M
(III) 55/M
Malignant thymoma, predominantly lymphocytic Peripheral T-cell lymphocytosis
Nemoto et al (1987) [4] 62/M Spindle cell thymoma (WHO type B3) Hodgkin's disease
Thomas et al (1983) [14] 40/M Invasive thymoma T-cell chronic lymphocytic leukemia
Skinnider et al (1982) [15] (I) 65/M (I) Epithelial thymoma (WHO type B3) (I) ‘Histiocytic lymphoma’
(II) 33/M (II) Mixed lymphoepithelial thymoma (WHO type AB) (II) Poorly differentiated lymphocytic lymphoma
Gould et al (1977) [16] 64/M Prevalent epithelial Lymphocytic lymphoma
CLL/SLL ¼ chronic lymphocytic leukemia/small lymphocytic lymphoma; NOS ¼ not otherwise speciﬁed; NR ¼ not reported; NS ¼ not speciﬁed.
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clonality assay (tube B) and immunoglobulin k light chain gene
clonality assay (tube A), were performed for both the right medi-
astinal tumor and supraclavicular lymph node. Both tissues showed
VH-FR2 and JH heavy chain gene rearrangements (not shown) and
Vk and Jk light chain gene rearrangement (Fig. 4).
A bone marrow biopsy showed negative results. Thus diffuse
large B-cell lymphoma Ann Arbor stage IIE was diagnosed.
The patient received complete chemotherapy with a regimen of
rituximab, cyclophosphamide, hydroxyl daunorubicin, vincristine,
and prednisone over 5 months. Two months later, positron emis-
sion tomographyecomputed tomography revealed complete
remission.
3. Discussion
During the past 5 decades, there have been sporadic reports of
thymomas associated with hematopoietic neoplasms (Table 1)
[3e16]. So far, the most common association is with T-cell neo-
plasms, including T-cell leukemia/lymphoma and T-cell lympho-
proliferative disorders. There are only isolated reports in English of
thymoma coexisting with B-cell lymphoma, one case with chronic
lymphocytic leukemia/small lymphocytic lymphoma [3], and one
with classic Hodgkin's lymphoma [4]. In these published cases, the
most common subtype of thymoma associated with concurrent or
composite hematopoietic neoplasms was type B1 thymoma.
There are two hypotheses regarding the relationship between
thymomas and lymphoproliferative disorders. One is that the
abnormal B-cell clone arises from aberrant stimulation or failed
suppression by abnormal T cells that mature in a dysfunctional
thymoma environment. This hypothesis is supported by the strong
association between T-cell immunodeﬁciency and B-cell malignant
neoplasms [5]. The other hypothesis is that the epithelium of the
thymoma retains the ability to stimulate T-cells, and this ongoing
stimulation predisposes to neoplasia [6]. In addition, association
with maturation of B-cells is via T helper cells (Th cells); T-cell
immunodeﬁciency may be more related to Th cells than T cytotoxic
cells (Tc cells).
Composite thymoma and lymphoma may be difﬁcult to di-
agnose, especially in lymphocyte-rich thymomas. By deﬁnition,
reactive lymphocytic proliferation is polyclonal. Hence, a combi-
nation of ancillary studies, such as ﬂow cytometric analysis, T-cellreceptor gene rearrangement analysis, B-cell clonality assay,
immunohistochemical study, and cytogenetic study, is necessary to
exclude a monoclonal lymphoproliferative disorder [3,5].
In conclusion, we describe a rare case of composite type A
thymoma and DLBCL involving the anteriormediastinumwith right
supraclavicular lymph node involvement. If composite thymoma
and lymphoma are suspected, a thorough examination of the thy-
moma with a combination of ancillary studies is recommended to
rule out the possibility of concurrent lymphoma.
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